RRC ID 42444
Author Karinaga R, Anada T, Minari J, Mizu M, Koumoto K, Fukuda J, Nakazawa K, Hasegawa T, Numata M, Shinkai S, Sakurai K.
Title Galactose-PEG dual conjugation of beta-(1-->3)-D-glucan schizophyllan for antisense oligonucleotides delivery to enhance the cellular uptake.
Journal Biomaterials
Abstract Antisense oligonucleotides (AS ODNs) are applied to silence a particular gene, and this approach is one of the potential gene therapies. However, naked oligonucleotides are easy to be degraded or absorbed in biological condition. Therefore, we need a carrier to deliver AS ODNs. This paper presents galactose moieties that were conjugated to the side chain of SPG to enhance cellular ingestion through endocytosis mediated by asialoglycoprotein receptor specifically located on parenchymal liver cells. We introduced galactose with two types of chemical bonds; amide and amine, and the amine connection showed lower ingestion and more toxicity than the amide one. Since PEG was known to induce endocytosis escape, we combined PEG and galactose aiming to provide both cellular up-take and subsequent endocytosis escape. We designed lactose or galactose moieties to attach to the end of the PEG chain that connects to the SPG side chain. When the PEG had the molecular weight of 5000-6000, the antisense effect reached the maximum. We believe that this new type of galactose and PEG dual conjugation broaden the horizon in antisense delivery.
Volume 27(8)
Pages 1626-35
Published 2006-3-1
DOI 10.1016/j.biomaterials.2005.08.023
PII S0142-9612(05)00771-4
PMID 16174528
MeSH Biocompatible Materials* Cell Line Cell Line, Tumor Drug Delivery Systems* Galactose* Humans Oligonucleotides, Antisense / metabolism* Polyethylene Glycols* Sizofiran* / chemical synthesis Sizofiran* / metabolism Sizofiran* / pharmacology beta-Glucans / chemical synthesis beta-Glucans / metabolism beta-Glucans / pharmacology*
IF 10.317
Times Cited 19
WOS Category ENGINEERING, BIOMEDICAL MATERIALS SCIENCE, BIOMATERIALS
Resource
Human and Animal Cells Hep G2